BMS 100 mg 3623 (Reyataz 100 mg)
Generic Name: atazanavir
This pill with imprint "BMS 100 mg 3623" is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
Reyataz
- Generic Name:
- atazanavir
- Imprint:
- BMS 100 mg 3623
- Strength:
- 100 mg
- Color:
- Blue & White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.
More about Reyataz (atazanavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Generic Availability
- Drug class: protease inhibitors
Consumer resources
- Reyataz
- Reyataz (Atazanavir Capsules)
- Reyataz (Atazanavir Powder for Oral Suspension)
- Reyataz (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
